Structural basis of cyclic nucleotide selectivity in cGMP dependent protein kinase II
- Baylor Univ., Waco, TX (United States). College of Medicine. Structural and computational Biology and Molecular Biophysics Program
- Rice Univ., Houston, TX (United States). Dept. of Biochemistry & Cell Biology
- Baylor Univ., Waco, TX (United States). College of Medicine. Dept. of Pharmacology
- Baylor Univ., Waco, TX (United States). College of Medicine. Verna and Marrs McLean Dept. of Biochemistry and Molecular Biology
- Univ. of Tokushima Graduate School (Japan). Dept. of Biological Science and Technology
- Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States). Berkeley Center for Structural Biology
- Univ. of Texas, Houston, TX (United States). MD Anderson Cancer Center. Dept. of Biochemistry and Molecular Biology
- Baylor Univ., Waco, TX (United States). College of Medicine. Structural and computational Biology and Molecular Biophysics Program; Univ. of Texas, Houston, TX (United States). MD Anderson Cancer Center. Dept. of Biochemistry and Molecular Biology
- Baylor Univ., Waco, TX (United States). College of Medicine. Structural and computational Biology and Molecular Biophysics Program; Baylor Univ., Waco, TX (United States). College of Medicine. Dept. of Pharmacology; Baylor Univ., Waco, TX (United States). College of Medicine. Verna and Marrs McLean Dept. of Biochemistry and Molecular Biology
As a central mediator of the natriuretic peptide-cGMP signalling cascade, membrane bound type II cGMP dependent protein kinase (PKG II) is a key regulator of bone growth, renin secretion, and memory formation. It represents an important drug target for treating osteoporosis, cystic fibrosis, and memory loss [1-5]. In spite of its crucial physiological roles and its importance as a therapeutic target, little is known about its mechanisms of cyclic nucleotide selectivity and activation due to a lack of structural information. PKG II contains an Nterminal regulatory (R)-domain that binds a C-terminal catalytic (C)-domain in the absence of cGMP. Binding of cGMP to the cyclic nucleotide binding domains (CNB-A and B) within the R-domain releases the C-domain, leading to activation. We sought to understand the cyclic nucleotide selectivity and activation mechanisms of PKG II by studying each CNB domain.
- Research Organization:
- Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC)
- Grant/Contract Number:
- AC02-05CH11231
- OSTI ID:
- 1629590
- Journal Information:
- BMC Pharmacology & Toxicology, Vol. 16, Issue S1; ISSN 2050-6511
- Publisher:
- BioMed CentralCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Crystal structure of cGMP-dependent protein kinase Iβ cyclic nucleotide-binding-B domain : Rp-cGMPS complex reveals an apo-like, inactive conformation
Co-Crystal Structures of PKG Iβ (92–227) with cGMP and cAMP Reveal the Molecular Details of Cyclic-Nucleotide Binding